ABIOMED Gross Profit vs. Price To Book

Based on the measurements of profitability obtained from ABIOMED's financial statements, ABIOMED may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess ABIOMED's ability to earn profits and add value for shareholders.
For ABIOMED profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ABIOMED to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ABIOMED utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ABIOMED's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ABIOMED over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please note, there is a significant difference between ABIOMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABIOMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABIOMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ABIOMED Price To Book vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ABIOMED's current stock value. Our valuation model uses many indicators to compare ABIOMED value to that of its competitors to determine the firm's financial worth.
ABIOMED is number one stock in gross profit category among its peers. It also is number one stock in price to book category among its peers . The ratio of Gross Profit to Price To Book for ABIOMED is about  75,786,528 . Comparative valuation analysis is a catch-all technique that is used if you cannot value ABIOMED by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

ABIOMED Price To Book vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

ABIOMED

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
843.6 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

ABIOMED

P/B

 = 

MV Per Share

BV Per Share

 = 
11.13 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

ABIOMED Price To Book Comparison

ABIOMED is currently under evaluation in price to book category among its peers.

ABIOMED Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ABIOMED, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ABIOMED will eventually generate negative long term returns. The profitability progress is the general direction of ABIOMED's change in net profit over the period of time. It can combine multiple indicators of ABIOMED, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.

ABIOMED Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ABIOMED. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ABIOMED position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ABIOMED's important profitability drivers and their relationship over time.

Use ABIOMED in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABIOMED position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABIOMED will appreciate offsetting losses from the drop in the long position's value.

ABIOMED Pair Trading

ABIOMED Pair Trading Analysis

The ability to find closely correlated positions to ABIOMED could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABIOMED when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABIOMED - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABIOMED to buy it.
The correlation of ABIOMED is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABIOMED moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABIOMED moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABIOMED can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ABIOMED position

In addition to having ABIOMED in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in ABIOMED Stock

If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets